MAP2K7 and melanoma: Somatic BRAF mutations have been found in nearly 60% of all melanoma, of which almost 90% harbor the V600E mutation, which results in the constitutive activation of MEK and ERK signaling, leading to increased cellular proliferation and survival and cancer progression [4,5].